These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7878915)

  • 21. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Count of major lymphocyte subsets and their mitogenic response after lethal irradiation and transplantation of syngeneic bone marrow from young and old donors].
    Butenko GM; Kudinov IuG; Maksiuk TV; Pishel' IN; Bazyka DA; Beliaeva NV; Azarskova MV
    Biull Eksp Biol Med; 1996 Sep; 122(9):301-4. PubMed ID: 8974486
    [No Abstract]   [Full Text] [Related]  

  • 23. Thalidomide induction of bone marrow transplantation tolerance.
    Vogelsang GB; Hess AD; Gordon G; Brundrette R; Santos GW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2658-61. PubMed ID: 3547944
    [No Abstract]   [Full Text] [Related]  

  • 24. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of allograft prolongation in RT6 T cell-depleted rats.
    Chen-Woan M; Greiner DL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):143-6. PubMed ID: 1824969
    [No Abstract]   [Full Text] [Related]  

  • 26. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapamycin effects on immunologic reconstitution.
    Vogelsang GB; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
    Hess AD; Thoburn CJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):518-29. PubMed ID: 16635787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ability of bone marrow cells and lymph node cells to induce tolerance of skin in MHC-congenic rats.
    Desquenne-Clark L; Kimura H; Silvers WK
    Transplantation; 1993 Dec; 56(6):1602-3. PubMed ID: 8279052
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP).
    Hess A; Thoburn C; Bright E; Horwitz L
    Transplant Proc; 1997; 29(1-2):725-7. PubMed ID: 9123499
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.
    Fischer AC; Ruvolo PP; Horwitz LR; Hess AD
    Transplant Proc; 1995 Feb; 27(1):1366-9. PubMed ID: 7878914
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antonio Raichs lecture. Graft versus host disease and the graft-against-leukemia reaction. Memorial lecture].
    Rozman C
    Sangre (Barc); 1990 Dec; 35(6):465-73. PubMed ID: 2087666
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperfractionation of total-body irradiation and engraftment of marrow from DLA-haploidentical littermates.
    Lösslein LK; Kolb HJ; Porzsolt S; Schäffer E; Scholz S; Meissner H; Holler E; Wilmanns W; Thierfelder S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2707-8. PubMed ID: 3079093
    [No Abstract]   [Full Text] [Related]  

  • 40. Depletion of RT6+ T lymphocytes prolongs skin allograft in rats.
    Chen-Woan M; Greiner DL; Mihalyo M; Schweizer RT
    Transplant Proc; 1989 Feb; 21(1 Pt 1):165-8. PubMed ID: 2650101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.